Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years,
ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease …

Low-density lipoprotein cholesterol is a well-known causal factor for atherosclerotic
cardiovascular disease, and is the primary target of lipid-lowering therapy. There is …

The purpose of this article is to review the basic and clinical science relating plasma
triglycerides and cardiovascular disease. Although many aspects of the basic physiology of …

Lipoproteins are a major risk factor for atherosclerotic cardiovascular diseases (ASCVD).
Among the lipoproteins, low-density lipoproteins (LDL) have been shown to be causally …

Compelling evidence from meta-analysis of a number of clinical studies on a large
aggregate of patients has established an increased level of triglycerides as an independent …

Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich
lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease …

Approximately 25% of US adults are estimated to have hypertriglyceridemia (triglyceride
[TG] level≥ 150 mg/dL [≥ 1.7 mmol/L]). Elevated TG levels are associated with increased …

Epidemiologic and clinical studies have demonstrated a relation between plasma
triglyceride levels and risk of coronary artery disease and an amplification of risk with …

Epidemiologic and clinical studies suggest that elevated triglyceride levels are a biomarker
of cardiovascular (CV) risk. Consistent with these findings, recent genetic evidence from …

Background Recent data suggest that triglyceride-rich lipoproteins may play a role in
atherogenesis. However, whether triglycerides, as a marker for these lipoproteins, represent …